Risk Factors for In Utero and Intrapartum Transmission of HIV
Laurence S Magder(University of Maryland, Baltimore), Kenneth Rich(University of Illinois Chicago), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Ruth Tuomala(Brigham and Women's Hospital), Carmen Zorrilla(University of Puerto Rico, Medical Sciences Campus), Sheldon H. Landesman(SUNY Downstate Health Sciences University), Mary E. Paul(Texas Children's Hospital), William A. Blattner(Unknown), Phil LaRussa(Columbia University)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 16, 2004
Cited by 156
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612